An optimum supply of omega-3 fatty acids is essential for maintaining the health and proper functioning of the brain. Research has shown that, in people with high levels of these nutrients, supplementing with a combination of B vitamins can prevent brain shrinkage, a hallmark of Alzheimer’s disease.
Other studies have made similar findings. People with high levels of the omega-3 fatty acid docosahexaenoic acid (DHA) are known to be at a 49 percent lower risk of developing Alzheimer’s. DHA has also been demonstrated to have beneficial effects on cognition in age-related cognitive decline.
A role is additionally emerging for omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders, Double-blind placebo-controlled pilot studies have shown that the omega-3 fatty acid eicosapentaenoic acid (EPA) is helpful in the treatment of schizophrenia. Significantly, therefore, patients suffering from schizophrenia and depression have been found to have low levels of omega-3 fatty acids.
To read about research showing that omega-3 supplements are helpful in the treatment of major depression, see this article on our website.
Global Diabetes Cases Expected To Soar From 529 Million To 1.3 Billion By 2050
July 14, 2023Taking Higher-Than-Recommended Doses Of Vitamin D For Five Years Reduces Risk Of Atrial Fibrillation
July 14, 2023Omega-3 Fatty Acids Maintain The Brain, Protect Against Degeneration
News
Regular intake of omega-3 fatty acids may protect the aging brain and provide peripheral biomarkers to predict the risk of cognitive degeneration or decline, according to a recent review.
[Source: nutraingredients-usa.com]
Comment
An optimum supply of omega-3 fatty acids is essential for maintaining the health and proper functioning of the brain. Research has shown that, in people with high levels of these nutrients, supplementing with a combination of B vitamins can prevent brain shrinkage, a hallmark of Alzheimer’s disease.
Other studies have made similar findings. People with high levels of the omega-3 fatty acid docosahexaenoic acid (DHA) are known to be at a 49 percent lower risk of developing Alzheimer’s. DHA has also been demonstrated to have beneficial effects on cognition in age-related cognitive decline.
A role is additionally emerging for omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders, Double-blind placebo-controlled pilot studies have shown that the omega-3 fatty acid eicosapentaenoic acid (EPA) is helpful in the treatment of schizophrenia. Significantly, therefore, patients suffering from schizophrenia and depression have been found to have low levels of omega-3 fatty acids.
To read about research showing that omega-3 supplements are helpful in the treatment of major depression, see this article on our website.
Dr. Rath Health Foundation
Related posts
France Records Growing Number of Supercentenarians
Read more